Starting in September, the UK’s new RSV vaccine program will offer protection across all age groups — find out what this ...

Who is eligible and what does it do? - The new jab is being offered to people across the UK ...

(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...

RSV, or respiratory syncytial virus, is a common cause of coughs and colds which can also lead to severe lung infections like pneumonia and infant bronchiolitis – conditions which are highly ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

The arrival of cooler weather and people gathering indoors can lead to the increased spread of COVID-19, influenza and ...

September brings so many things: Changing leaves, seasonal flavors and the run-up to respiratory virus season.

As the 2024-2025 respiratory virus season gets under way, statewide infectious disease experts urge everyone in Oregon to ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

Oregon health officials want to make sure everyone is safe and protected this respiratory virus season with vaccinations and ...

Respiratory syncytial virus (RSV) is a respiratory disease accompanied by cold-like symptoms. RSV can be cured within a week or two in most of the cases but still it’s very fatal for one’s health.

as the presentation is indistinguishable from other respiratory tract infections, and epidemics often overlap. The microbiologic confirmation of RSV infection is based on detecting the virus in a ...